BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32818697)

  • 1. Functional Confirmation of DNA Repair Defect in Ataxia Telangiectasia (AT) Infants Identified by Newborn Screening for Severe Combined Immunodeficiency (NBS SCID).
    Barmettler S; Coffey K; Smith MJ; Chong HJ; Pozos TC; Seroogy CM; Walter J; Abraham RS
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):723-732.e3. PubMed ID: 32818697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.
    Mandola AB; Reid B; Sirror R; Brager R; Dent P; Chakroborty P; Bulman DE; Roifman CM
    Front Immunol; 2019; 10():2940. PubMed ID: 31921190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for SCID identifies patients with ataxia telangiectasia.
    Mallott J; Kwan A; Church J; Gonzalez-Espinosa D; Lorey F; Tang LF; Sunderam U; Rana S; Srinivasan R; Brenner SE; Puck J
    J Clin Immunol; 2013 Apr; 33(3):540-9. PubMed ID: 23264026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn Screening for Severe Combined Immunodeficiency.
    Routes J; Verbsky J
    Curr Allergy Asthma Rep; 2018 May; 18(6):34. PubMed ID: 29749587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents' Perspective on Ataxia Telangiectasia.
    Blom M; Schoenaker MHD; Hulst M; de Vries MC; Weemaes CMR; Willemsen MAAP; Henneman L; van der Burg M
    Front Immunol; 2019; 10():2438. PubMed ID: 31781088
    [No Abstract]   [Full Text] [Related]  

  • 6. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
    Kwan A; Church JA; Cowan MJ; Agarwal R; Kapoor N; Kohn DB; Lewis DB; McGhee SA; Moore TB; Stiehm ER; Porteus M; Aznar CP; Currier R; Lorey F; Puck JM
    J Allergy Clin Immunol; 2013 Jul; 132(1):140-50. PubMed ID: 23810098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen.
    Kubala SA; Sandhu A; Palacios-Kibler T; Ward B; Harmon G; DeFelice ML; Bundy V; Younger MEM; Lederman H; Liang H; Anzabi M; Ford MK; Heimall J; Keller MD; Lawrence MG
    Clin Immunol; 2022 Dec; 245():109182. PubMed ID: 36368643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for SCID: three years of experience.
    Chase NM; Verbsky JW; Routes JM
    Ann N Y Acad Sci; 2011 Nov; 1238():99-105. PubMed ID: 22129057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia.
    Puck JM
    Immunol Rev; 2019 Jan; 287(1):241-252. PubMed ID: 30565242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for SCID: lessons learned.
    Buelow BJ; Verbsky JW; Routes JM
    Expert Rev Hematol; 2016 Jun; 9(6):579-84. PubMed ID: 27139719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API).
    Speckmann C; Nennstiel U; Hönig M; Albert MH; Ghosh S; Schuetz C; Brockow I; Hörster F; Niehues T; Ehl S; Wahn V; Borte S; Lehmberg K; Baumann U; Beier R; Krüger R; Bakhtiar S; Kuehl JS; Klemann C; Kontny U; Holzer U; Meinhardt A; Morbach H; Naumann-Bartsch N; Rothoeft T; Kreins AY; Davies EG; Schneider DT; Bernuth HV; Klingebiel T; Hoffmann GF; Schulz A; Hauck F
    J Clin Immunol; 2023 Jul; 43(5):965-978. PubMed ID: 36843153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for SCID in New York State: experience from the first two years.
    Vogel BH; Bonagura V; Weinberg GA; Ballow M; Isabelle J; DiAntonio L; Parker A; Young A; Cunningham-Rundles C; Fong CT; Celestin J; Lehman H; Rubinstein A; Siegel S; Weiner L; Saavedra-Matiz C; Kay DM; Caggana M
    J Clin Immunol; 2014 Apr; 34(3):289-303. PubMed ID: 24578017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
    Mantravadi V; Bednarski JJ; Ritter MA; Gu H; Kolicheski AL; Horner C; Cooper MA; Kitcharoensakkul M
    Front Immunol; 2021; 12():734096. PubMed ID: 34539671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn Screening for Severe Combined Immunodeficiency: 10-Year Experience at a Single Referral Center (2009-2018).
    Thorsen J; Kolbert K; Joshi A; Baker M; Seroogy CM
    J Clin Immunol; 2021 Apr; 41(3):595-602. PubMed ID: 33409868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
    Richards S; Pitt J; Choo S
    J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for SCID: where are we now?
    Buelow BJ; Routes JM; Verbsky JW
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1649-57. PubMed ID: 25387596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Severe Combined Immunodeficiency.
    Taki M; Miah T; Secord E
    Pediatr Clin North Am; 2019 Oct; 66(5):913-923. PubMed ID: 31466681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel.
    Lev A; Sharir I; Simon AJ; Levy S; Lee YN; Frizinsky S; Daas S; Saraf-Levy T; Broides A; Nahum A; Hanna S; Stepensky P; Toker O; Dalal I; Etzioni A; Stein J; Adam E; Hendel A; Marcus N; Almashanu S; Somech R
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2722-2731.e9. PubMed ID: 35487367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic Infant With Atypical SCID and Novel Hypomorphic
    Chitty-Lopez M; Westermann-Clark E; Dawson I; Ujhazi B; Csomos K; Dobbs K; Le K; Yamazaki Y; Sadighi Akha AA; Chellapandian D; Oshrine B; Notarangelo LD; Sunkersett G; Leiding JW; Walter JE
    Front Immunol; 2020; 11():1954. PubMed ID: 33117328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.